Chook, some questions to add to your list if they aren’t answered in the newsletter. Thanks.
Restructuring
Projected annual costs savings from the restructuring undertaken this year?
Oxymorphone Patch
If tesa Labtec successfully resolves the oxy-m formulation issues, will the next step be tech transfer from Germany to POH's US-based CMO?
Oxycodone Patch
If the current trial in PHN fails, is it still intended to proceed with a trial in a second indication such as knee OA?
If the current trial succeeds, does the topical oxy-c patch have to undergo the same pre-IND testing process as the oxy-m patch before being used in trials in the US?
TPM Injectable
Is this collaboration with Mylan/Agila still alive? If so, is the company able to provide any guidance as to when FDA approval might be sought?
Publication
Have further papers been submitted for publication or are about to be submitted for publication?
Steve Meller
Is Steve Meller still working as a consultant for the company? If so, has he been looking happy lately?
POH Price at posting:
1.5¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)